Abstract CN01-03: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Keyword(s):
T Cell
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 3043-3043
◽